Literature DB >> 7095783

Clinical lab: managing the products of automation.

S G Kernaghan.   

Abstract

Mesh：

Year:  1982        PMID： 7095783

Source DB:  PubMed          Journal:  Hospitals        ISSN： 0018-5973


× No keyword cloud information.
  8 in total

Review 1.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.

Authors:  Adriana Albini; Giovanni Di Guardo; Douglas McClain Noonan; Michele Lombardo
Journal:  Intern Emerg Med       Date:  2020-05-19       Impact factor: 3.397

Review 3.  Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration.

Authors:  Mahsa Dolatshahi; Mohammadmahdi Sabahi; Mohammad Hadi Aarabi
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

4.  Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.

Authors:  Rongjuan Pei; Jianqi Feng; Yecheng Zhang; Hao Sun; Lian Li; Xuejie Yang; Jiangping He; Shuqi Xiao; Jin Xiong; Ying Lin; Kun Wen; Hongwei Zhou; Jiekai Chen; Zhili Rong; Xinwen Chen
Journal:  Protein Cell       Date:  2020-12-12       Impact factor: 14.870

5.  Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.

Authors:  Amirreza Roostaei Firozabad; Zohreh Akhoundi Meybodi; Seyed Ruhollah Mousavinasab; Adeleh Sahebnasagh; Mohsen Gholinataj Jelodar; Iman Karimzadeh; Solomon Habtemariam; Fatemeh Saghafi
Journal:  BMC Infect Dis       Date:  2021-03-24       Impact factor: 3.090

6.  Pathogenesis-based preexposure prophylaxis associated with a low risk of SARS-CoV-2 infection in healthcare workers at a designated COVID-19 hospital: a pilot study.

Authors:  Michael V Dubina; Veronika V Gomonova; Anastasia E Taraskina; Natalia V Vasilyeva; Sergey A Sayganov
Journal:  BMC Infect Dis       Date:  2021-06-07       Impact factor: 3.090

7.  SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Andrzej Ciechanowicz; Kasia Sielatycka; Monika Cymer; Wojciech Marlicz; Magda Kucia
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

Review 8.  Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.

Authors:  Michele Catanzaro; Francesca Fagiani; Marco Racchi; Emanuela Corsini; Stefano Govoni; Cristina Lanni
Journal:  Signal Transduct Target Ther       Date:  2020-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.